Dirks-Naylor Amie J, Kouzi Samir A, Bero Joseph D, Tran Ngan Tk, Yang Sendra, Mabolo Raean
Amie J Dirks-Naylor, Samir A Kouzi, Joseph D Bero, Ngan TK Tran, Sendra Yang, Raean Mabolo, School of Pharmacy, Wingate University, Wingate, NC 28174, United States.
World J Biol Chem. 2014 Aug 26;5(3):377-86. doi: 10.4331/wjbc.v5.i3.377.
To determine if doxorubicin (Dox) alters hepatic proteome acetylation status and if acetylation status was associated with an apoptotic environment.
Doxorubicin (20 mg/kg; Sigma, Saint Louis, MO; n = 8) or NaCl (0.9%; n = 7) was administered as an intraperitoneal injection to male F344 rats, 6-wk of age. Once animals were treated with Dox or saline, all animals were fasted until sacrifice 24 h later.
Dox treatment decreased proteome lysine acetylation likely due to a decrease in histone acetyltransferase activity. Proteome deacetylation may likely not be associated with a proapoptotic environment. Dox did not increase caspase-9, -8, or -3 activation nor poly (adenosine diphosphate-ribose) polymerase-1 cleavage. Dox did stimulate caspase-12 activation, however, it likely did not play a role in apoptosis induction.
Early effects of Dox involve hepatic proteome lysine deacetylation and caspase-12 activation under these experimental conditions.
确定阿霉素(Dox)是否会改变肝脏蛋白质组的乙酰化状态,以及乙酰化状态是否与凋亡环境相关。
对6周龄雄性F344大鼠腹腔注射阿霉素(20mg/kg;Sigma,圣路易斯,密苏里州;n = 8)或氯化钠(0.9%;n = 7)。用阿霉素或生理盐水处理动物后,所有动物禁食直至24小时后处死。
阿霉素处理降低了蛋白质组赖氨酸乙酰化,这可能是由于组蛋白乙酰转移酶活性降低所致。蛋白质组去乙酰化可能与促凋亡环境无关。阿霉素未增加半胱天冬酶-9、-8或-3的激活,也未增加聚(二磷酸腺苷核糖)聚合酶-1的切割。然而,阿霉素确实刺激了半胱天冬酶-12的激活,但它可能在凋亡诱导中不起作用。
在这些实验条件下,阿霉素的早期作用涉及肝脏蛋白质组赖氨酸去乙酰化和半胱天冬酶-12激活。